CClinicalTrials.gg
CompletedNCT03015545Updated Dec 10, 2018

The Effects of WBV on Muscle Stiffness and Reflex Activity in Stroke.

An interventional study of paretic leg-control and paretic leg-WBV in Stroke, sponsored by The Hong Kong Polytechnic University. Completed at 1 site in Hong Kong. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-12-10.

Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Spastic hypertonia is common after stroke. Whole-body vibration (WBV) is known to have modulatory effects of muscle reflex activity and blood flow in other populations and thus have potential applications in the management of spastic hypertonia post-stroke. This study aims to investigate the acute effect of WBV on leg muscle H-reflex, stiffness, and blood perfusion in people with chronic stroke.

Read the detailed description

Spastic hypertonia is common after stroke. Whole-body vibration (WBV) is known to have modulatory effects of muscle reflex activity and blood flow in other populations and thus have potential applications in management of spastic hypertonia post-stroke. However, the potential effects of WBV on leg muscle stiffness in stroke rehabilitation remains unknown. Scientific evidence is warranted to fill the knowledge gap.

Purpose This study aims to investigate the acute effect of WBV on leg muscle H-reflex, stiffness and blood perfusion in people with chronic stroke.

Methods Individuals with chronic stroke will be recruited from community self-help groups and existing patient database. Relevant information (e.g. demographic information, medical history) will be obtained from medical records and subject interviews. Each subject will have to fulfill the following inclusion criteria: (1) diagnosis of chronic stroke, (2) community-dwelling, (3) able to follow simple verbal instructions. Exclusion criteria are: (1) other diagnoses of neurological conditions, (2) significant musculoskeletal conditions (e.g. amputations), (3) metal implants in the lower extremity or spine, (4) recent fracture in the lower extremity, (5) diagnosis of osteoporosis, (6) vestibular disorders, (7) peripheral vascular disease, and (11) other serious illnesses or contraindications to exercise.

This is a single-blinded randomized within-patient cross-over study. Each participant was evaluated for the soleus H-reflex, stiffness and blood perfusion of the medial gastrocnemius (MG) using ultrasound on both sides before and after either a 5-minute WBV intervention (30 Hertz, 1.5mm, knee flexed 60 degrees) or a no-WBV condition (5 minutes). The measurements were performed at baseline and every 1-min post-intervention up to 5 minutes. The outcomes generated included the soleus H/M ratio, shear modulus and vascular index (VI) of the MG muscle.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Muscle Stiffness
  • Ultrasound elastography
  • H-reflex
  • Whole body vibration
  • blood perfusion
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 36 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 659 studies on the registry; 250 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Adult with a diagnosis of a hemispheric stroke >6 months,
  2. Medically stable,
  3. Able to stand independently for at least 1 minute and
  4. Mas score >1 measured at the ankle plantar flexors.

Exclusion criteria

Exclusion Criteria:

  1. Brainstem or cerebellar stroke,
  2. Other neurological condition,
  3. Serious musculoskeletal or cardiovascular disease,
  4. Severe contracture of the ankle that the cannot be put in the neutral position.
  5. Metal implants or recent fractures in the lower extremities or spine,
  6. Fresh skin wound in lower extremities, especially popliteal fossa
  7. Other severe illnesses or contraindication for exercise.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (actual)

Study arms

  • Active comparator
    Control

    This group will stand with knee flexion 60 degrees on the same vibration platform for 60 seconds for 5 times with 60-seconds rest interval, but no vibration will be given.

    Device: paretic leg-control · Device: non-paretic leg-control

  • Active comparator
    High intensity whole body vibration

    This group will stand with knee flexion 60 degrees on the same vibration platform for 60 seconds for 5 times with 60-seconds rest interval. The whole body vibration platform will be set with frequency at 30Hz and amplitude at 1.5mm.

    Device: paretic leg-WBV · Device: non-paretic leg-WBV

Interventions

  • Deviceparetic leg-control

    standing on the vibration platform, with no vibration signals delivered.

  • Deviceparetic leg-WBV

    standing on the vibration platform, with WBV at 30Hz, 1.5mm.

  • Devicenon-paretic leg-control

    standing on the vibration platform, with no vibration signals delivered.

  • Devicenon-paretic leg-WBV

    standing on the vibration platform, with WBV at 30Hz, 1.5mm.

06

What researchers measure

Primary outcomes

  1. H-reflex of paretic soleus muscle

    To measure the efficacy of synaptic transmission

    Time frame: Immediately before the intervention

  2. H-reflex of paretic soleus muscle

    To measure the efficacy of synaptic transmission

    Time frame: 1st minute after the intervention

  3. H-reflex of paretic soleus muscle

    To measure the efficacy of synaptic transmission

    Time frame: 2nd minute after the intervention

  4. H-reflex of paretic soleus muscle

    To measure the efficacy of synaptic transmission

    Time frame: 3rd minute after the intervention

  5. H-reflex of paretic soleus muscle

    To measure the efficacy of synaptic transmission

    Time frame: 4th minute after the intervention

  6. H-reflex of paretic soleus muscle

    To measure the efficacy of synaptic transmission

    Time frame: 5th minute after the intervention

  7. Muscle stiffness of paretic medial gastrocnemius

    Measured by Supersonic elastography with ankle in neutral position

    Time frame: Immediately before the intervention

  8. Muscle stiffness of paretic medial gastrocnemius

    Measured by Supersonic elastography with ankle in neutral position

    Time frame: 1st minute after the intervention

  9. Muscle stiffness of paretic medial gastrocnemius

    Measured by Supersonic elastography with ankle in neutral position

    Time frame: 2nd minute after the intervention

  10. Muscle stiffness of paretic medial gastrocnemius

    Measured by Supersonic elastography with ankle in neutral position

    Time frame: 3rd minute after the intervention

  11. Muscle stiffness of paretic medial gastrocnemius

    Measured by Supersonic elastography with ankle in neutral position

    Time frame: 4th minute after the intervention

  12. Muscle stiffness of paretic medial gastrocnemius

    Measured by Supersonic elastography with ankle in neutral position

    Time frame: 5th minute after the intervention

  13. H-reflex of non-paretic soleus muscle

    To measure the efficacy of synaptic transmission

    Time frame: Immediately before the intervention

  14. H-reflex of non-paretic soleus muscle

    To measure the efficacy of synaptic transmission

    Time frame: 1st minute after the intervention

  15. H-reflex of non-paretic soleus muscle

    To measure the efficacy of synaptic transmission

    Time frame: 2nd minute after the intervention

  16. H-reflex of non-paretic soleus muscle

    To measure the efficacy of synaptic transmission

    Time frame: 3rd minute after the intervention

  17. H-reflex of non-paretic soleus muscle

    To measure the efficacy of synaptic transmission

    Time frame: 4th minute after the intervention

  18. H-reflex of non-paretic soleus muscle

    To measure the efficacy of synaptic transmission

    Time frame: 5th minute after the intervention

  19. Muscle stiffness of non-paretic medial gastrocnemius

    Measured by Supersonic elastography with ankle in neutral position

    Time frame: Immediately before the intervention

  20. Muscle stiffness of non-paretic medial gastrocnemius

    Measured by Supersonic elastography with ankle in neutral position

    Time frame: 1st minute after the intervention

  21. Muscle stiffness of non-paretic medial gastrocnemius

    Measured by Supersonic elastography with ankle in neutral position

    Time frame: 2nd minute after the intervention

  22. Muscle stiffness of non-paretic medial gastrocnemius

    Measured by Supersonic elastography with ankle in neutral position

    Time frame: 3th minute after the intervention

  23. Muscle stiffness of non-paretic medial gastrocnemius

    Measured by Supersonic elastography with ankle in neutral position

    Time frame: 4th minute after the intervention

  24. Muscle stiffness of non-paretic medial gastrocnemius

    Measured by Supersonic elastography with ankle in neutral position

    Time frame: 5th minute after the intervention

Secondary outcomes

  1. Intramuscular blood perfusion of paretic medial gastrocnemius muscle

    Measured by power Doppler ultrasound

    Time frame: Immediately before the intervention

  2. Intramuscular blood perfusion of paretic medial gastrocnemius muscle

    Measured by power Doppler ultrasound

    Time frame: 1 minute after the intervention

  3. Intramuscular blood perfusion of paretic medial gastrocnemius muscle

    Measured by power Doppler ultrasound

    Time frame: 2nd minute after the intervention

  4. Intramuscular blood perfusion of paretic medial gastrocnemius muscle

    Measured by power Doppler ultrasound

    Time frame: 3rd minute after the intervention

  5. Intramuscular blood perfusion of paretic medial gastrocnemius muscle

    Measured by power Doppler ultrasound

    Time frame: 4th minute after the intervention

  6. Intramuscular blood perfusion of paretic medial gastrocnemius muscle

    Measured by power Doppler ultrasound

    Time frame: 5th minute after the intervention

  7. Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle

    Measured by power Doppler ultrasound

    Time frame: Immediately before the intervention

  8. Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle

    Measured by power Doppler ultrasound

    Time frame: 1th minute after the intervention

  9. Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle

    Measured by power Doppler ultrasound

    Time frame: 2nd minute after the intervention

  10. Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle

    Measured by power Doppler ultrasound

    Time frame: 3rd minute after the intervention

  11. MoviIntramuscular blood perfusion of non-paretic medial gastrocnemius muscle

    Measured by power Doppler ultrasound

    Time frame: 4th minute after the intervention

  12. Intramuscular blood perfusion of non-paretic medial gastrocnemius muscle

    Measured by power Doppler ultrasound

    Time frame: 5th minute after the intervention

Other outcomes

  1. Fugl-Meyer Assessment of Motor Recovery after Stroke--lower extremities

    Evaluates and measures motor recovery in post-stroke hemiplegic patients

    Time frame: Immediately before the intervention

  2. Brief Balance Evaluation Systems Test

    Time frame: Immediately before the intervention

07

Study locations

1 site
  • The Hong Kong Polytechnic University
    Hung Hom, Kowloon, Hong Kong
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 10, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03015545
Lead sponsor
The Hong Kong Polytechnic University
Responsible party
Marco Yiu-Chung Pang (Professor, The Hong Kong Polytechnic University) — Principal investigator
First posted
Jan 10, 2017
Start date
May 1, 2017
Primary completion
Sep 3, 2017
Completion
Dec 31, 2017
Last update
Dec 10, 2018

Study contacts

Hector WH Tsang, PhD
study chair · Department of Rehabilitation Sciences, The Hong Kong Polytechnic University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion